Epigenomics Announces Layoffs, Product Line Cancellation in Restructuring
The firm is halting sale of Epi proColon and recalling the product as well as reducing its employee headcount after failing to raise additional capital.
People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Jan. 23, 2023.
In Brief This Week: Yourgene, Centogene, Epigenomics, AnPac Bio-Medical, Biodesix, SomaLogic
News items for the week of Dec. 19, 2022.
The firm has commercialized its pancreatic cancer test and has its sights set on an ovarian cancer test launching in 2023.
Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
The firm will evaluate its epigenomic liquid biopsy test to detect pancreatic cancer among patients considered high-risk for the disease due to their diabetes.
Dec 2, 2022
Aug 11, 2021
Epigenomics H1 Revenues Down 31 Percent
Jan 7, 2021
Epigenomics Issues €5.5M Convertible Bond
Nov 12, 2020
Epigenomics Posts 30 Percent Rise in Q3 Revenues
May 7, 2020
Epigenomics Q1 Revenues Down 28 Percent
Apr 29, 2020